basal
cell
carcinoma
bcc
common
type
human
skin
cancer
driven
aberr
activ
hedgehog
signal
previou
evid
indic
sex
determin
region
ybox
associ
tumor
metastasi
howev
express
role
bcc
remain
unknown
therefor
aim
current
studi
analyz
possibl
mechan
progress
bcc
level
bcc
cell
detect
revers
transcriptionquantit
polymeras
chain
reaction
transwel
assay
also
use
determin
migrat
invas
bcc
cell
immunoblot
immunofluoresc
use
analyz
role
knockdown
serinearginin
protein
kinas
mediat
phosphoinositid
kinas
b
signal
pathway
bcc
cell
result
demonstr
overexpress
bcc
tissu
cell
addit
knockdown
inhibit
migrat
invas
bcc
cell
epithelialmesenchym
transit
emt
progress
bcc
cell
also
observ
knockdown
decreas
express
led
downregul
akt
express
level
bcc
cell
furthermor
transfect
pathway
activ
abolish
inhibitori
effect
knockdown
migrat
invas
emt
progress
bcc
cell
conclus
result
indic
may
potenti
serv
target
bcc
therapi
target
signal
pathway
basal
cell
carcinoma
bcc
one
common
type
human
skin
cancer
character
mutat
patch
andor
smoothen
gene
aberr
express
hedgehog
signal
pathway
epidemiolog
studi
report
bcc
associ
exposur
radiat
variou
popul
includ
atom
bomb
survivor
radiologist
intervent
cardiologist
current
exposur
uv
ray
common
caus
bcc
onset
gener
popul
numer
possibl
mechan
propos
pathogenesi
bc
dna
damag
certain
cell
signal
pathway
howev
variou
regulatori
factor
involv
chronolog
progress
bcc
lesion
also
requir
investig
sex
determin
region
sri
box
member
sryrel
high
mobil
group
box
famili
wide
report
involv
human
carcinogenesi
sever
malign
recent
observ
present
complet
distinct
effect
differ
tumor
type
previou
studi
indic
promot
develop
certain
type
cancer
includ
osteosarcoma
colorect
cancer
glioblastoma
prostat
cancer
breast
cancer
ovarian
cancer
exhibit
inhibitori
role
gastric
cancer
squamou
cell
lung
cancer
find
suggest
may
regard
tumorassoci
gene
human
cancer
addit
multivari
analysi
demonstr
express
may
prognost
factor
cancer
patient
howev
regulatori
role
potenti
mechan
remain
elus
bcc
previou
studi
indic
epithelialmesenchym
transit
emt
signal
implic
invas
metastasi
variou
type
human
cancer
addit
report
inhibit
serinearginin
protein
kinas
suppress
prostat
cancer
progress
modul
vegf
altern
splice
furthermor
phosphoinositid
kinas
b
signal
pathway
particip
signal
transduct
tumor
cell
therefor
present
studi
investig
role
invas
metastasi
bcc
cell
hypothes
regulatori
effect
exert
signal
pathway
clinic
tissu
total
malefemal
bcc
tissu
match
adjac
nontumor
tissu
collect
depart
dermatolog
second
hospit
tianjin
medic
univers
tianjin
china
may
june
patholog
diagnosi
bcc
patient
mean
age
year
rang
perform
accord
world
health
organ
criteria
patient
histori
cancer
histori
exclud
present
studi
bcc
tissu
store
embed
paraffin
none
patient
receiv
chemotherapi
radiotherapi
treatment
prior
tumor
resect
patient
requir
provid
written
inform
consent
studi
also
approv
ethic
committe
tianjin
medic
univers
gener
hospit
cell
cultur
bcc
normal
cell
obtain
bcc
tissu
match
adjac
nontumor
tissu
respect
describ
previous
cell
maintain
dulbecco
modifi
eagl
medium
dmem
sigmaaldrich
merck
kgaa
darmstadt
germani
supplement
fetal
bovin
serum
fb
sigmaaldrich
merck
kgaa
uml
penicillin
streptomycin
sodium
pyruv
lglutamin
atmospher
co
immunohistochem
ihc
analysi
bcc
normal
tissu
section
obtain
patient
deparaffin
xylen
rehydr
grade
ethanol
follow
block
endogen
peroxidas
activ
hydrogen
peroxid
min
room
temperatur
sampl
analyz
express
use
immunostain
previous
describ
briefli
tumor
section
incub
specif
primari
antibodi
abcam
cambridg
usa
h
tumor
tissu
incub
monoclon
horseradish
peroxidas
hrp
conjug
goat
antirabbit
igg
antibodi
origen
technolog
inc
beij
china
ventana
benchmark
autom
stain
system
use
examin
protein
express
tumor
tissu
tucson
az
usa
stain
result
semiquantit
evalu
base
percentag
posit
stain
cell
magnif
rna
extract
quantit
polymeras
chain
reaction
qpcr
total
cellular
rna
extract
bcc
normal
cell
use
rneasi
mini
kit
qiagen
scienc
inc
gaithersburg
md
usa
accord
manufactur
protocol
total
rna
revers
transcrib
cdna
use
high
capac
cdna
revers
transcript
kit
product
code
appli
biosystem
next
mrna
express
determin
cdna
subject
qpcr
use
iq
sybr
green
supermix
biorad
laboratori
inc
hercul
ca
usa
primer
synthes
invitrogen
thermo
fisher
scientif
inc
waltham
usa
follow
forward
gag
ttg
tca
agg
cag
revers
gag
ttg
tca
agg
cag
forward
agt
caa
cgg
att
tgg
revers
ctt
ctc
cat
ggt
cgt
pcr
thermocycl
condit
includ
amplif
cycl
denatur
sec
primer
anneal
sec
primer
extens
sec
rel
level
mrna
express
calcul
use
method
result
express
fold
chang
rel
normal
control
compar
level
target
mrna
express
control
group
western
blot
bcc
cell
homogen
lysi
buffer
contain
proteas
inhibitor
sigmaaldrich
merck
kgaa
centrifug
x
g
min
sd
assay
perform
describ
previous
subsequ
block
skim
milk
h
follow
primari
antibodi
dilut
ad
membran
akt
ecadherin
vimentin
fibronectin
purchas
abcam
membran
incub
monoclon
hrpconjug
goat
antirabbit
igg
secondari
antibodi
origen
technolog
inc
h
ventana
benchmark
autom
stain
system
tucson
az
usa
use
analyz
protein
express
small
interf
rna
sirna
transfect
bcc
cell
cellswel
seed
incub
h
next
medium
remov
optimem
invitrogen
thermo
fisher
scientif
inc
ad
h
sirna
sequenc
correspond
gene
design
synthes
genepharma
co
ltd
shanghai
china
follow
cag
uac
aac
ucc
aug
utg
guu
cgg
ugg
uca
sirnavector
control
guc
uca
uug
atg
aca
total
pmol
sirna
transfect
cultur
bcc
cell
respect
use
lipofectamin
rnaimax
reagent
invitrogen
thermo
fisher
scientif
inc
follow
incub
h
cell
use
analysi
lentiviru
product
cell
transduct
packag
plasmid
envelop
plasmid
purchas
invitrogen
thermo
fisher
scientif
inc
pwpxlvector
pvector
vector
transfect
bcc
cell
bcc
cell
use
lipofectamin
invitrogen
thermo
fisher
scientif
inc
follow
incub
h
treat
cell
use
investig
effect
gene
deplet
use
prolifer
migrat
invas
western
blot
assay
cell
prolifer
assay
bcc
cell
transfect
pvector
sirnavector
vector
seed
plate
cellswel
cultur
day
follow
incub
medium
remov
cell
fix
methanol
stain
wv
crystal
violet
sigmaaldrich
merck
kgaa
cell
coloni
count
use
imagepro
plu
version
softwar
media
cybernet
inc
bethesda
md
usa
cell
migrat
invas
analysi
bcc
cell
transfect
bcc
transfect
bcc
cell
treat
mg
sigmaaldrich
merck
kgaa
h
migrat
invas
assay
bcc
cell
serumfre
dmem
place
upper
chamber
plate
densiti
cellswel
dmem
lower
chamber
supplement
fb
sigmaaldrich
merck
kgaa
transwel
insert
pore
size
emd
millipor
billerica
usa
uncoat
coat
matrigel
use
evalu
cell
migrat
invas
respect
h
bcc
cell
lower
chamber
fix
paraformaldehyd
min
stain
crystal
violet
dye
sigmaaldrich
merck
kgaa
min
subsequ
cell
count
randomli
select
field
view
use
light
microscop
olympu
olympu
corpor
immunofluoresc
assay
immunofluoresc
perform
previous
describ
brief
ly
bcc
cell
cultur
plate
h
bcc
cell
wash
phosphatebuff
salin
fix
paraformaldehyd
sigmaaldrich
min
cell
rins
phosphatebuff
salin
permeabil
triton
min
subsequ
cell
incub
h
indic
antibodi
follow
ecadherin
vimentin
fibronectin
purchas
abcam
cell
treat
fluorescein
isothiocyanateconjug
donkey
antirabbit
igg
polyclon
antibodi
jackson
immunoresearch
laboratori
inc
west
grove
pa
usa
h
final
cell
examin
use
microscop
leica
b
leica
microsystem
gmbh
wetzlar
germani
statist
analysi
data
express
mean
standard
deviat
least
three
independ
replic
data
analyz
spss
softwar
version
ibm
corp
armonk
ny
usa
graphpad
prism
version
graphpad
softwar
inc
la
jolla
ca
usa
use
oneway
analysi
varianc
follow
tukey
multipl
comparison
post
hoc
test
p
p
valu
consid
indic
differ
statist
signific
express
bcc
tissu
cell
line
bcc
tissu
sampl
patient
bcc
cell
line
use
analyz
express
demonstr
overexpress
bcc
tissu
sampl
compar
normal
basal
tissu
determin
ihc
stain
fig
shown
fig
demonstr
express
upregul
bcc
tissu
compar
normal
tissu
gene
protein
express
level
also
upregul
bcc
cell
line
compar
normal
basal
cell
line
fig
result
suggest
express
level
upregul
bcc
tissu
cell
knockdown
inhibit
bcc
cell
migrat
invas
vitro
role
bcc
cell
next
analyz
observ
knockdown
transfect
markedli
downregul
express
overexpress
transfect
markedli
upregul
express
bcc
cell
indic
transfect
success
perform
fig
b
result
demonstr
overexpress
promot
cell
migrat
invas
fig
knockdown
inhibit
migrat
invas
bcc
cell
fig
f
result
suggest
express
associ
bcc
cell
migrat
invas
previou
studi
suggest
emt
process
critic
regul
progress
cancer
metastasi
therefor
effect
emt
process
bcc
cell
analyz
result
reveal
overexpress
promot
bcc
cell
prolifer
wherea
knockdown
inhibit
bcc
cell
prolifer
fig
b
addit
knockdown
upregul
express
epitheli
marker
ecadherin
inhibit
level
mesenchym
marker
vimentin
fibronectin
bcc
cell
contrast
overexpress
caus
revers
effect
emt
process
marker
bcc
cell
fig
immunofluoresc
assay
also
confirm
effect
knockdown
overexpress
epitheli
mesenchym
marker
express
level
bcc
cell
fig
f
result
indic
express
regul
emt
process
prolifer
bcc
cell
previou
studi
indic
associ
human
cancer
metastasi
elucid
potenti
molecular
mechan
mediat
express
analyz
bcc
cell
result
demonstr
transfect
promot
express
knockdown
inhibit
express
bcc
cell
fig
b
addit
knockdown
observ
result
mark
reduct
cell
migrat
invas
fig
howev
overexpress
promin
cancel
knockdowninhibit
migrat
invas
bcc
cell
compar
control
fig
f
furthermor
knockdown
downregul
emt
process
bcc
cell
observ
increas
ecadherin
decreas
level
vimentin
fibronectin
fig
contrast
overexpress
cancel
knockdowninhibit
emt
process
bcc
cell
fig
data
suggest
direct
target
emt
process
bcc
cell
previou
studi
indic
promot
activ
signal
metastasi
human
cancer
present
studi
associ
signal
pathway
explor
bcc
cell
shown
fig
b
knockdown
markedli
decreas
express
level
akt
bcc
cell
overexpress
significantli
increas
level
also
observ
knockdown
markedli
decreas
express
level
akt
bcc
cell
wherea
overexpress
increas
level
fig
howev
activ
pathway
abrog
inhibitori
effect
knockdown
bcc
cell
migrat
invas
fig
f
thu
result
suggest
knockdown
inhibit
bcc
cell
invas
signal
pathway
sever
studi
indic
express
markedli
increas
human
cancer
tissu
compar
normal
tissu
includ
ovarian
prostat
cancer
present
studi
express
bcc
tissu
cell
line
determin
result
indic
overexpress
bcc
tissu
cell
line
recent
express
report
associ
lymph
node
metastas
distant
invas
rightsid
colon
cancer
suggest
also
regul
tumorigenesi
find
current
studi
indic
regul
bcc
cell
migrat
invas
target
emt
signal
pathway
although
associ
express
progress
sever
human
cancer
cell
report
function
role
potenti
mechan
bcc
examin
previous
current
role
remain
controversi
differ
cancer
type
present
studi
observ
upregul
bcc
differ
sox
gene
protein
express
may
result
translat
effici
sox
bcc
tissu
cell
yang
et
al
report
promot
migrat
invas
laryng
cancer
cell
induct
matrix
via
target
rapamycin
pathway
howev
yoon
et
al
indic
overexpress
associ
better
overal
surviv
squamou
cell
lung
cancer
patient
treat
adjuv
radiotherapi
present
studi
report
knockdown
inhibit
bcc
cell
migrat
invas
downregul
emt
signal
pathway
highli
conserv
protein
dysregul
differ
type
cancer
inhibit
regard
potenti
target
therapeut
strategi
prostat
cancer
therapi
previou
studi
indic
serv
critic
role
emt
process
human
glioblastoma
current
studi
demonstr
potenti
target
express
decreas
knockdown
bcc
cell
addit
downregul
mediat
knockdown
regul
emt
process
bcc
cell
result
inhibit
migrat
invas
furthermor
also
report
downregul
inhibit
signal
pathway
therefor
reduc
express
may
lead
suppress
bcc
metastasi
previou
studi
demonstr
function
oncogen
via
promot
activ
signal
numer
report
also
suggest
activ
signal
pathway
involv
develop
progress
human
cancer
regul
invas
cancer
cell
current
studi
result
demonstr
knockdown
downregul
signal
pathway
bcc
cell
notabl
serv
crucial
role
emt
process
prolifer
invas
lung
cancer
cell
also
involv
paclitaxel
resist
prostat
cancer
cell
line
via
pathway
current
studi
report
activ
signal
pathway
abrog
effect
knockdown
bcc
cell
migrat
invas
therefor
pathway
may
involv
role
migrat
invas
bcc
cell
conclus
present
studi
find
indic
serv
pivot
role
bcc
cell
migrat
invas
target
signal
pathway
suggest
may
novel
potenti
therapeut
target
bcc
applic
fund
receiv
analyz
data
set
gener
studi
avail
correspond
author
reason
request
zl
yj
perform
experi
present
studi
jh
yc
analyz
data
ql
design
experi
present
studi
present
studi
approv
ethic
committe
tianjin
medic
univers
gener
hospit
studi
particip
provid
consent
public
data
